Kernicterus Hyperbilirubinemia Injury Lawyers in Miami

Breakpoint 1: The Bilirubin Was Never Checked Before Discharge

The AAP Clinical Practice Guideline on the management of hyperbilirubinemia in newborns 35 weeks and above (as published by the American Academy of Pediatrics and endorsed as the national standard for neonatal jaundice management) recommends universal bilirubin screening before hospital discharge. A transcutaneous bilirubinometer pressed against the infant’s sternum gives a reading in seconds. That reading, plotted against the infant’s age in hours on the Bhutani nomogram, tells the physician whether the baby is safe to go home or whether the trajectory is headed toward a dangerous zone. In the kernicterus cases we handle across Miami-Dade County, the first failure is often the simplest: the test was never performed. The baby was born, appeared healthy, and was discharged at 18 or 24 hours of age without a bilirubin level ever being drawn. The discharge summary will say “infant tolerating feeds, no jaundice noted.” Two days later, the baby is back in the ER with a total serum bilirubin above 25 mg/dL and signs of acute bilirubin encephalopathy. The hospital’s own discharge protocol required the test. The chart proves it was not done.

Breakpoint 2: The Number Was Plotted Wrong or Ignored on the Nomogram

Sometimes the bilirubin is checked. The number comes back. And then nothing happens. A total serum bilirubin of 14 mg/dL at 24 hours of life plots into the high intermediate risk zone on the Bhutani nomogram. That zone requires a repeat bilirubin within 8 to 12 hours and close follow up after discharge. But if the physician reads the number in isolation without plotting it against the infant’s age in hours, 14 may look reassuring. “Normal” bilirubin in the first days of life depends entirely on the clock. A level that is safe at 72 hours is dangerous at 24 hours because the trajectory matters more than the snapshot. The nomogram exists to force the physician to consider the trajectory. When the nomogram is not used, or when the number is plotted incorrectly, the infant is discharged into a rising bilirubin curve without the safety net that should have caught it.

Breakpoint 3: The Parents Called. They Were Told to Wait.

This is the failure that haunts the families we represent. The baby is home. The skin looks yellow. The baby is not latching. The baby sleeps through feedings and is difficult to wake. The parents call the pediatrician’s office or the hospital nursery and describe these symptoms. They are told the baby is “just sleepy,” that jaundice is “very common in newborns,” that they should try again at the next feeding and come in for a weight check in a few days.

What the parents do not know is that the symptoms they described, lethargy, poor feeding, difficulty arousing, are the clinical hallmarks of acute bilirubin encephalopathy. They are not signs of a sleepy baby. They are signs that bilirubin is crossing the blood-brain barrier and depositing in the basal ganglia and brainstem nuclei. By the time the family returns to the hospital and the total serum bilirubin comes back above 30 mg/dL, the window for effective phototherapy may have closed. Emergency exchange transfusion may or may not reverse the damage already done. The phone log, the triage notes, and the after-hours call record document exactly what the parents reported and exactly what the medical team told them to do. That record is the backbone of the case.

The Bhutani nomogram is the single most important piece of evidence in a kernicterus case. Published in 1999 by Dr. Vinod Bhutani and adopted into the AAP guidelines, this hour-specific bilirubin nomogram divides newborns into four risk zones based on two data points: the total serum bilirubin level and the infant’s age in hours at the time of the measurement. A bilirubin of 12 mg/dL at 18 hours of life falls into the high risk zone. The same bilirubin at 72 hours falls into the low intermediate zone. The clinical response required by each zone is different. The high risk zone demands repeat testing in hours and consideration of immediate phototherapy. The low intermediate zone permits discharge with routine follow up.

In Miami birth injury litigation, our neonatology experts take the bilirubin values documented in the hospital record, plot each one on the nomogram at the exact hour of life it was drawn, and reconstruct the trajectory the medical team should have seen. If the infant’s bilirubin was crossing from intermediate into high risk and the team did not escalate treatment, we can demonstrate with mathematical precision the hour at which the intervention should have occurred and the hour at which it actually did. The gap between those two points is where the brain damage happened. The defense cannot argue that the nomogram does not apply. It is the national standard. It was available on every computer in that hospital. The question is whether anyone opened it.

Athetoid (dyskinetic) cerebral palsy is the form of CP most closely associated with kernicterus. Unlike the spastic diplegia that follows PVL, athetoid CP produces involuntary writhing movements, fluctuating muscle tone, and difficulty maintaining posture. The child may have normal or near-normal intelligence trapped inside a body that will not cooperate. This distinction matters for damages because a child with athetoid CP often understands their limitations fully, which compounds the non-economic impact of the injury.

Auditory neuropathy spectrum disorder (ANSD) is the second hallmark. Bilirubin damages the auditory nerve pathways, producing a form of hearing loss that is different from the sensorineural loss caused by other conditions. The cochlea may function normally while the nerve transmission to the brain is disrupted. Standard hearing aids often do not help. Cochlear implants may be indicated, but outcomes vary. Speech development is delayed or absent, and the cost of auditory rehabilitation, speech therapy, and communication technology extends across the child’s entire life.

Dental enamel dysplasia, upward gaze palsy, and cognitive processing deficits round out the kernicterus phenotype. The dental enamel abnormalities result from bilirubin deposition during tooth development. The gaze palsy reflects damage to the brainstem oculomotor pathways. The cognitive deficits may be subtle or significant depending on the extent of the bilirubin exposure. Each of these findings, documented in the child’s medical and dental records, corroborates the MRI pattern and strengthens the causal link between the untreated hyperbilirubinemia and the lifelong injury.

A kernicterus Life Care Plan is built around the specific constellation of deficits this injury produces. For the motor component: adaptive seating systems, gait trainers, and wheelchairs with replacement schedules projected through life expectancy, plus physical therapy and occupational therapy multiple times per week from childhood through adulthood. For the auditory component: cochlear implant evaluation, surgical implantation if indicated, device maintenance and upgrades, auditory verbal therapy, and speech-language pathology services that may be required for years. For the dental component: specialty pediatric dental care and restorative work necessitated by enamel dysplasia. For the cognitive and educational component: individualized education plans, assistive communication technology, cognitive rehabilitation, and vocational support. For the daily living component: attendant care ranging from part-time assistance to 24 hour supervision depending on severity, home modifications for accessibility, and modified vehicle for transportation. Loss of future earning capacity is calculated by a vocational economist based on what the child would have earned absent the injury. These projections are inflation adjusted and extend across the full life expectancy established by our medical experts.

The Attorney Who Knows How the Hospital Will Defend This Case

The defense in a kernicterus case follows a script that Attorney Jorge L. Flores memorized while working on the other side. Before founding this firm, he worked as an attorney for a leading insurance defense firm in Miami defending hospitals against birth injury claims. The hospital will argue that the jaundice was “physiologic” and within normal limits for the infant’s age. Their expert will testify that the bilirubin level “did not meet the threshold for phototherapy” at the time of discharge. They will blame the parents for not bringing the baby back sooner. They will argue that the infant had an “underlying hemolytic condition” that made kernicterus unavoidable regardless of the care provided.

Jorge Flores has heard every one of these arguments from the inside of the defense conference room. He knows which ones collapse under cross examination when the plaintiff’s attorney can place the bilirubin on the Bhutani nomogram at the exact hour of life and show the jury that the number was in the high risk zone before the baby ever left the hospital. The defense needs ambiguity to survive. We eliminate it.

Jaundice Is Common. Brain Damage From Jaundice Is a Never Event.

The bilirubin was either checked or it was not. The nomogram was either consulted or it was not. Phototherapy was either started or it was not. The medical record answers every one of these questions.

(305) 598-2221